
Glimalog MP 2mg/500mg/15mg Tablet
Marketer
Biolog Pharma Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimalog MP 2mg/500mg/15mg Tablet
Metformin/glimepiride/pioglitazone 2mg/500mg/15mg tablets offer a combined approach to managing blood glucose. This medication, used alongside a healthy diet and exercise regimen, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, thus reducing elevated blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Ingestion with food is recommended to mitigate gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Excessive medication can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted prior to initiating therapy. Limit alcohol consumption to minimize the potential for adverse reactions.
Uses of Glimalog MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimalog MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimalog MP 2mg/500mg/15mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
Common Side effects of Glimalog MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimalog MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimalog MP 2mg/500mg/15mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medicine with a meal.
How Glimalog MP 2mg/500mg/15mg Tablet works:
Glimalog MP 2mg/500mg/15mg tablets contain a triple combination of glimepiride, metformin, and pioglitazone to manage blood sugar. This formulation employs diverse mechanisms of action, offering superior glycemic control when monotherapy or dual-drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimalog MP 2mg/500mg/15mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimalog MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimalog MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glimalog MP 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, the use of Glimalog MP 2mg/500mg/15mg tablets is contraindicated. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimalog MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimalog MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimalog MP 2mg/500mg/15mg Tablet :
Should you forget a dose of Glimalog MP 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimalog MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Treatment | Medication for diabetes |
